SPIKEVAX

moderna biopharma canada corporation🇨🇦 Health Canada

Approval Id: aaf2af1b70c61691
Drug Approval Canada Name: SPIKEVAX
Product Name: SPIKEVAX
Status: Cancelled Post Market
Status Date: 2024-01-19
Original Market Date: 2022-07-14
Din: 02527685
Drug Class: Human
Dosage Form: Dispersion
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BN01 COVID-19, RNA-BASED VACCINE
Atc Name: j 07 bn 01
Aig Number: 0162662002
Company Name: moderna biopharma canada corporation
Company Address: 3130, 155 Wellington Street West, Toronto, Ontario, Canada, M5V 3H1

ELASOMERAN

0.1 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

aaf2af1b70c61691

Type

Standard